The overall prevalence of BRCA1-2 mutations among breast cancer patients from the entire Sardinia was quite similar to that previously reported for breast-ovarian cancer families originating from the Northern part of the island (for both studies, 15% BRCA-positive carriers were observed in breast-ovarian cancer families [14,18]. This evidence concerns the gene BRCA1 and breast cancer.